138 related articles for article (PubMed ID: 26186879)
1. The multiple origin of cancer stem cells in hepatocellular carcinoma.
Anfuso B; El-Khobar KE; Sukowati CH; Tiribelli C
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S92-7. PubMed ID: 26186879
[TBL] [Abstract][Full Text] [Related]
2. Biology of hepatic cancer stem cells.
Tong CM; Ma S; Guan XY
J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
Chiba T; Kamiya A; Yokosuka O; Iwama A
Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
[TBL] [Abstract][Full Text] [Related]
4. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
5. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Hepatic Cancer Stem Cells.
Sukowati CHC
Adv Exp Med Biol; 2019; 1139():59-81. PubMed ID: 31134495
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms of hepatocellular carcinoma: an update.
Aravalli RN; Cressman EN; Steer CJ
Arch Toxicol; 2013 Feb; 87(2):227-47. PubMed ID: 23007558
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of hepatocellular carcinoma contributes to cancer progression.
Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ
Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939
[TBL] [Abstract][Full Text] [Related]
9. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomic analysis of cancer stem cell properties in hepatocellular carcinomas by isobaric tag labeling and mass spectrometry.
Ko CH; Cheng CF; Lai CP; Tzu TH; Chiu CW; Lin MW; Wu SY; Sun CY; Tseng HW; Wang CC; Kuo ZK; Wang LM; Chen SF
J Proteome Res; 2013 Aug; 12(8):3573-85. PubMed ID: 23782096
[TBL] [Abstract][Full Text] [Related]
11. Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy.
Roskams T
Clin Liver Dis; 2011 May; 15(2):245-59, vii-x. PubMed ID: 21689611
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic target for cancer stem cells in hepatocellular carcinoma.
Nagano H; Ishii H; Marubashi S; Haraguchi N; Eguchi H; Doki Y; Mori M
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):600-5. PubMed ID: 22892595
[TBL] [Abstract][Full Text] [Related]
13. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.
Sukowati CH; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):749-57. PubMed ID: 24161136
[TBL] [Abstract][Full Text] [Related]
14. Origin of hepatocellular carcinoma: role of stem cells.
Wu XZ; Chen D
J Gastroenterol Hepatol; 2006 Jul; 21(7):1093-8. PubMed ID: 16824058
[TBL] [Abstract][Full Text] [Related]
15. Cellular prognostic markers in hepatocellular carcinoma.
Buonaguro L; Tagliamonte M; Petrizzo A; Damiano E; Tornesello ML; Buonaguro FM
Future Oncol; 2015; 11(11):1591-8. PubMed ID: 26043213
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
17. Proliferative drive and liver carcinogenesis: too much of a good thing?
Teoh NC
J Gastroenterol Hepatol; 2009 Dec; 24(12):1817-25. PubMed ID: 20002941
[TBL] [Abstract][Full Text] [Related]
18. Collecting evidence for a stem cell hypothesis in HCC.
Teufel A; Galle PR
Gut; 2010 Jul; 59(7):870-1. PubMed ID: 20581232
[No Abstract] [Full Text] [Related]
19. APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.
Nguyen CB; Houchen CW; Ali N
Exp Biol Med (Maywood); 2017 Feb; 242(3):242-249. PubMed ID: 27694285
[TBL] [Abstract][Full Text] [Related]
20. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
